Creative Medical Technology Holdings, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Creative Medical Technology Holdings, Inc. (CELZ) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 643.56 thousand shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2022-11-10
- Creative Medical Technology Holdings, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2021-03-31 was 64.79M shares, a 1240.09% increase year-over-year.
- Creative Medical Technology Holdings, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2020-09-30 was 47.78K shares.
- Creative Medical Technology Holdings, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2020-03-31 was 4.83M shares.
- Creative Medical Technology Holdings, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2021 was 643.56K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | 643.56K shares 10-K · filed 2022-03-30 | ||||||
| 2021-09-30 | 50.14K shares 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | 35.87K shares 10-Q · filed 2022-08-12 | 17.94M shares 10-Q · filed 2021-08-16 | |||||
| 2021-03-31 | 64.79M shares 10-Q · filed 2022-05-13 | ||||||
| 2020-09-30 | 47.78K shares 10-Q · filed 2021-11-15 | 23.89M shares 10-Q · filed 2020-11-13 | 56.31K shares 10-Q · filed 2021-11-15 | 28.16M shares 10-Q · filed 2020-11-13 | |||
| 2020-06-30 | 12.98M shares 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | 4.83M shares 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |